RISA Labs AI Operating System for Oncology

RISA Labs is an AI operating system for oncology that automates prior authorization, medication access and other workflows that delay patient care. It serves cancer centers, infusion centers, specialty pharmacies and health systems.

The platform covers Part B and Part D prior authorization across portals, APIs and e-fax, real-time eligibility and benefit verification written back to the EHR, claims status tracking, denial management and custom rules-driven workflows. Partner institutions shown include Tennessee Oncology, OneOncology and Mary Bird Perkins Cancer Center.

• Prior Authorization: Part B and Part D execution across portals, APIs and e-fax.
• Eligibility and Benefit Verification: real-time checks written back to the EHR.
• Claims Status: tracking and reconciliation against authorizations and payments.
• Denial Management: detection, classification and appeals.
• Custom Workflows: rules-driven flows tailored to each practice.
• Platform layers: action models, intelligence layer and traceability.

Cancer hospitals could automate insurance verification for expensive therapies. Specialty pharmacies could track authorizations and denials in one place.

• End-to-end prior authorization execution across portals, APIs and e-fax.
• Real-time coverage checks written back to the EHR.
• Closed-loop denial detection and appeals.
• Workflows configurable to each practice's SOPs and payer mix.

Oncology practices face heavy prior authorization and denial workloads, driving agentic AI for access workflows. Vietnamese cancer hospitals handling insurance approvals and costly drug access may see similar administrative load.

USD 11.1M Series A reported in Jan 2026, co-led by Cencora Ventures and Optum Ventures with Oncology Ventures and Z21 Ventures. Site shows HIPAA, HITECH, SOC and ISO 27001 badges.